TALPHERA, INC. Net Income (Loss) Attributable to Parent, Diluted
TALPHERA, INC. (TLPH) reported Net Income (Loss) Attributable to Parent, Diluted of -$5.75 million for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-11-10.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToParentDiluted · last filed 2014-11-10
- TALPHERA, INC. net income (loss) attributable to parent, diluted for the quarter ending 2014-09-30 was -$5.75M.
- TALPHERA, INC. net income (loss) attributable to parent, diluted for the quarter ending 2014-06-30 was -$13.08M.
- TALPHERA, INC. net income (loss) attributable to parent, diluted for the quarter ending 2013-09-30 was -$10.99M.
- TALPHERA, INC. net income (loss) attributable to parent, diluted for the quarter ending 2013-06-30 was -$17.45M.
| Period end | Net Income (Loss) Attributable to Parent, Diluted 3 month | Net Income (Loss) Attributable to Parent, Diluted 6 month | Net Income (Loss) Attributable to Parent, Diluted 9 month |
|---|---|---|---|
| 2014-09-30 | -$5.75M 10-Q · filed 2014-11-10 | -$18.83M derived: sum of 2 quarters · filed 2014-11-10 | -$27.78M 10-Q · filed 2014-11-10 |
| 2014-06-30 | -$13.08M 10-Q · filed 2014-08-11 | -$22.03M 10-Q · filed 2014-08-11 | |
| 2013-09-30 | -$10.99M 10-Q · filed 2014-11-10 | -$28.43M derived: sum of 2 quarters · filed 2014-11-10 | -$41.20M 10-Q · filed 2014-11-10 |
| 2013-06-30 | -$17.45M 10-Q · filed 2014-08-11 | -$30.21M 10-Q · filed 2014-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |